Synairgen plc
31 October 2007
Synairgen plc ('Synairgen' or the 'Company')
Director Shareholdings
The Company was informed on 31 October 2007 that Richard Marsden, Managing
Director of Synairgen, had been granted options on 30 October 2007 over 129,853
ordinary shares of 1 pence each ('Ordinary Shares') in the Company under the
Company's Long-Term Incentive Plan (the 'LTIP') at an exercise price of 1 pence
per share.
Mr Marsden's holding in options over Ordinary Shares has therefore increased to
944,288, representing approximately 4.35 per cent. of the issued ordinary share
capital of the Company.
The Company was informed on 31 October 2007 that John Ward, Finance Director of
Synairgen, had been granted options on 30 October 2007 over 118,048 Ordinary
Shares in the Company under the Company's LTIP at an exercise price of 1 pence
per share.
Mr Ward's holding in options over Ordinary Shares has therefore increased to
631,723, representing approximately 2.91 per cent. of the issued ordinary share
capital of the Company.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.